Author (Corporate) | European Medicines Agency |
---|---|
Series Title | Press Release |
Series Details | EMA/296130/2013 (17.05.13) |
Publication Date | 17/05/2013 |
Content Type | News |
The European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP), on 17 May 2013, recommended the marketing authorisation for Aftovaxpur DOE for use in response to outbreaks of foot-and-mouth disease (FMD). The vaccine is intended for active immunisation of cattle and sheep from 2 months of age and pigs from 10 weeks of age to reduce clinical signs of the disease. The applicant for Aftovaxpur DOE is Merial. |
|
Source Link | Link to Main Source http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/05/news_detail_001791.jsp&mid=WC0b01ac058004d5c1 |
Related Links |
|
Subject Categories | Business and Industry |
Countries / Regions | Europe |